A detailed history of Drw Securities, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Drw Securities, LLC holds 2,643 shares of MRK stock, worth $262,317. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,643
Previous 2,700 2.11%
Holding current value
$262,317
Previous $334,000 10.18%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $559,529 - $649,234
-5,034 Reduced 65.57%
2,643 $300,000
Q2 2024

Aug 13, 2024

SELL
$123.8 - $132.96 $1.39 Million - $1.5 Million
-11,248 Reduced 59.43%
7,677 $950,000
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $1.27 Million - $1.48 Million
11,209 Added 145.27%
18,925 $2.5 Million
Q4 2023

Feb 16, 2024

BUY
$100.18 - $109.02 $772,988 - $841,198
7,716 New
7,716 $841,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $793,287 - $864,647
-7,304 Reduced 61.13%
4,645 $536,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $1.23 Million - $1.37 Million
11,949 New
11,949 $1.27 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $694,302 - $787,026
-8,316 Reduced 61.93%
5,112 $466,000
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $455,394 - $510,468
6,195 Added 85.65%
13,428 $1.1 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $522,801 - $654,875
7,233 New
7,233 $554,000
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $641,607 - $705,607
-8,951 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $629,344 - $696,119
8,951 New
8,951 $696,000
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $1.95 Million - $2.27 Million
-38,328 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $1.98 Million - $2.36 Million
38,328
38,328 $2.16 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.